The urolithins suppress colon cancer cell proliferation, activate cell cycle cessation, and amend specific cellular processes linked with colon cancer progression, such as mitogen-activated protein kinase (MAPK) signaling [9]. This evidence concerns the gene WNK2 and malignant colon neoplasm.